Rowland Mbaoma
Hematology & Oncology · Munster, INNPI 1174562151
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in IN, where the typical reported total is $3,829.
Across 139 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$393
- Amgen$330
- Pfizer$192
- Merck$177
- E.r. Squibb & Sons, L.L.C.$177
- Genentech USA, Inc.$158
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,30391%
- Education$2279%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 24 | $393 |
| Amgen | 9 | $330 |
| Pfizer | 13 | $192 |
| Merck | 14 | $177 |
| E.r. Squibb & Sons, L.L.C. | 11 | $177 |
| Genentech USA, Inc. | 10 | $158 |
| Novartis | 7 | $131 |
| Tesaro, Inc. | 3 | $121 |
| AstraZeneca(2 entities) | 6 | $105 |
| Bayer | 4 | $78 |
| Bristol Myers Squibb | 3 | $65 |
| EMD Serono, Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Eisai Inc. | 2 | $45 |
| Exelixis Inc. | 2 | $43 |
| Incyte Corporation | 3 | $41 |
| Sanofi | 2 | $36 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $32 |
| Kyowa Kirin, Inc. | 2 | $31 |
| Puma Biotechnology, Inc. | 2 | $30 |
| AMAG Pharmaceuticals, Inc. | 2 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 2 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Seagen Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Aurobindo Pharma USA, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Gilead | 1 | $13 |
| Fortovia Therapeutics, Inc. | 1 | $11 |
How this compares
$2,529 in reported general payments places this provider in the 40th percentile of 224 hematology & oncology providers in Indiana.
Other hematology & oncology in Munster
- Ghassan JanoMunster$20K
- Richard GaynorIndianapolis$3.7M
- Ruemu BirhirayIndianapolis$3.1M
- Chandler ParkCorydon$661K
- Neel ShahDyer$464K
- Ahad SadiqFort Wayne$430K
- Ajay KandraMadison$408K
- Anand TandraIndianapolis$280K
- Attaya SuvannasankhaIndianapolis$253K
- Michael DuganIndianapolis$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.